2024-03-01 2025-02-28 false Capium Accounts Production 1.1 08004990 2024-03-01 2025-02-28 08004990 bus:AbridgedAccounts 2024-03-01 2025-02-28 08004990 bus:FRS102 2024-03-01 2025-02-28 08004990 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-02-28 08004990 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 08004990 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 08004990 2024-03-01 2025-02-28 08004990 2025-02-28 08004990 bus:RegisteredOffice 2024-03-01 2025-02-28 08004990 core:WithinOneYear 2025-02-28 08004990 core:AfterOneYear 2025-02-28 08004990 1 2024-03-01 2025-02-28 08004990 bus:Director1 2024-03-01 2025-02-28 08004990 bus:Director1 2025-02-28 08004990 bus:Director1 2023-03-01 2024-02-29 08004990 2023-03-01 08004990 bus:LeadAgentIfApplicable 2024-03-01 2025-02-28 08004990 2023-03-01 2024-02-29 08004990 2024-02-29 08004990 core:WithinOneYear 2024-02-29 08004990 core:AfterOneYear 2024-02-29 08004990 bus:EntityAccountantsOrAuditors 2023-03-01 2024-02-29 08004990 core:MotorCars 2024-03-01 2025-02-28 08004990 core:MotorCars 2025-02-28 08004990 core:MotorCars 2024-02-29 08004990 core:FurnitureFittings 2024-03-01 2025-02-28 08004990 core:FurnitureFittings 2025-02-28 08004990 core:FurnitureFittings 2024-02-29 08004990 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-02-28 08004990 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-02-29 08004990 core:NetGoodwill 2024-03-01 2025-02-28 08004990 core:NetGoodwill 2025-02-28 08004990 core:NetGoodwill 2024-02-29 08004990 core:CostValuation core:Non-currentFinancialInstruments 2025-02-28 08004990 core:CostValuation core:Non-currentFinancialInstruments 2024-02-29 08004990 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-02-28 08004990 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-02-28 08004990 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-02-28 08004990 core:Non-currentFinancialInstruments 2025-02-28 08004990 core:Non-currentFinancialInstruments 2024-02-29 08004990 core:ShareCapital 2025-02-28 08004990 core:ShareCapital 2024-02-29 08004990 core:RetainedEarningsAccumulatedLosses 2025-02-28 08004990 core:RetainedEarningsAccumulatedLosses 2024-02-29 08004990 dpl:Item1 2024-03-01 08004990 dpl:Item1 2025-02-28 08004990 dpl:Item1 2023-03-01 08004990 dpl:Item1 2024-02-29 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 08004990
PHARM-X LTD
Abridged Accounts
Period of accounts Start date: 01 March 2024 End date: 28 February 2025

PHARM-X LTD Contents Page For the year ended 28 February 2025
Accountants' report | 1
Statement of financial position | 2
Notes to the financial statements | 3

PHARM-X LTD Accountants' Report For the year ended 28 February 2025
Accountant’s report You consider that the company is exempt from an audit for the year ended 28 February 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. Myrtle Gund Ltd 28 February 2025 .................................................... Myrtle Gund Ltd 248 Lockwood Road Huddersfield HD1 3TG 19 November 2025 1

PHARM-X LTD Statement of Financial Position As at 28 February 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Intangible fixed assets | 3 | 400,000 |  | 425,000
Tangible fixed assets | 4 | 73,298 |  | 31,653
|  | 473,298 |  | 456,653
Current assets |  |  |
Stocks |  | 48,000 |  | 48,000
Debtors |  | 267,782 |  | 236,298
Cash at bank and in hand |  | 90,215 |  | 141,849
|  | 405,997 |  | 426,147
Creditors: amount falling due within one year |  | (323,854) |  | (323,368)
Net current assets |  | 82,143 |  | 102,779
Total assets less current liabilities |  | 555,441 |  | 559,432
Creditors: amount falling due after more than one year |  | (239,304) |  | (252,673)
Net assets |  | 316,137 |  | 306,759
Capital and reserves |  |  |
Called up share capital |  | 100 |  | 100
Profit and loss account |  | 316,037 |  | 306,659
Shareholders' funds |  | 316,137 |  | 306,759
For the year ended 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the director on 19 November 2025 and were signed by:
------------------------------- Mohammed Eftikar Director
2

PHARM-X LTD Notes to the Abridged Financial Statements For the year ended 28 February 2025
General Information PHARM-X LTD is a private company, limited by shares, registered in , registration number 08004990, registration address 29-31 Rushby Street, Fir Vale, Sheffield, S4 8GN. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Goodwill Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of 20 years. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Motor Vehicles | 25% Reducing Balance
Fixtures and Fittings | 20% Reducing Balance
2. | Average number of employees Average number of employees during the year was 5 (2024 : 5).
3. | Intangible fixed assets
Cost | Goodwill |  | Total
| £ |  | £
At 01 March 2024 | 500,000 |  | 500,000
Additions | - |  | -
Disposals | - |  | -
At 28 February 2025 | 500,000 |  | 500,000
Amortisation
At 01 March 2024 | 75,000 |  | 75,000
Charge for year | 25,000 |  | 25,000
On disposals | - |  | -
At 28 February 2025 | 100,000 |  | 100,000
Net book values
At 28 February 2025 | 400,000 |  | 400,000
At 29 February 2024 | 425,000 |  | 425,000
4. | Tangible fixed assets
Cost or valuation | Motor Vehicles |  | Fixtures and Fittings |  | Total
| £ |  | £ |  | £
At 01 March 2024 | 52,246 |  | 3,442 |  | 55,688
Additions | 64,583 |  | - |  | 64,583
Disposals | - |  | - |  | -
At 28 February 2025 | 116,829 |  | 3,442 |  | 120,271
Depreciation
At 01 March 2024 | 20,889 |  | 3,146 |  | 24,035
Charge for year | 22,879 |  | 59 |  | 22,938
On disposals | - |  | - |  | -
At 28 February 2025 | 43,768 |  | 3,205 |  | 46,973
Net book values
Closing balance as at 28 February 2025 | 73,061 |  | 237 |  | 73,298
Opening balance as at 01 March 2024 | 31,357 |  | 296 |  | 31,653
3